期刊文献+

喹诺酮类抗生素临床应用态势及合理用药 被引量:5

The Progress and Clinical Application of Ratinal Drug Use about Quinolone Antibiotics
下载PDF
导出
摘要 喹诺酮类(QNS)药物是一类分子中具有喹诺酮或萘啶结构的人工合成抗菌化合物,是近年来迅速发展起来的抗菌药物。具有抗菌谱广、抗菌力强、结构简单、给药方便,与其他常用抗菌药物无交叉耐药性以及价格便宜等特点,愈来愈受到各国的重视,在临床上的应用越来越广泛。但是不容忽视的是该类药物所引起的不良反应及禁忌证亦多,临床医务人员必须熟悉这些药物,既充分发挥这些药物的治疗作用,又可防止药源性疾病的发生。 Quinolones is in a kind of member has Quinolones the naphthyridine structure synthesized antibacterial compound, was the recent years rapidly expand antibiotics. Has the antibacterial spectrum broadly, the antibacterial strength to be strong, the structure simple, is convenient to the medicine, with other commonly used characteristics and so on antibiotics not cross-tolerance as well as price small advantage, receives various countries' more and more value, the application is getting more and more widespread on clinical. What but is not allow to neglect is this kind of medicine causes the untoward effect and the taboo card are also many, the clinical medical personnel must be familiar with these medicines, both displays these medicines fully the therapeutic action, and may prevent the medicine source disease's occurrence.
作者 冉启文
出处 《中国医药指南》 2009年第12期41-43,共3页 Guide of China Medicine
关键词 喹诺酮类 临床应用 药物相互作用 Quinolones Clinical practice Medicine interaction
  • 相关文献

参考文献9

二级参考文献23

  • 1何国钧.抗结核药物的研究进展[J].中国防痨杂志,1996,18(3):136-139. 被引量:47
  • 2荒田次郎 森健一 等.格雷沙星与氧氟沙星对皮肤细菌感染症的双盲多中心比较试验成绩[J].日本化学疗法学会杂志,1997,45(7):506-506.
  • 3[1]Hosaka M,Yaxue T, Fukuda H, Tomizawa H, et al.In vitro and in vivo antibacterial activities of AM-1 155, a new 6-fluoro-8-methoxy quinolone. Antimicrobial Agents Chemotherapy, 1992;36:2108~2117.
  • 4[2]Wakabayashi E, Mitsuhashi S. In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methyoxy quinolone. Antimicrobial Agents Chemotherapy, 1994;38:594~601.
  • 5[3]Wise R, Brenwald NP, Andrews JM,et al. The activity of the methylpiperazinyl fluoroquinolone CG5501:A comparison with other fluoroquinolones fluoroquinolones. Antimicrobial Chemotherapy, 1997;39:447~452.
  • 6[4]National Committee for Clinical Laboratory Standards. 1998;18.
  • 7[5]Hosaka M,Kinoshita S, Toyama A,et al. Antibacterial Properties of AM-1155, a new 8-methoxy quinolone. Antimicrobial Chemotherapy, 1995; 36:293~301.
  • 8[6]Tanaka M,Takahashi K, Saika T, et al. Development of fluoroquinoloneresistance and mutations involving GyrA and ParC proteins among Neisseria gonorrhoeae in Japan. Urology, 1998; 159:2215~2219.
  • 9[7]Deguchi T, Yasuda M, Nakano M,ea al. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GryA and ParC.Chemotherapy, 1997;43:239~244.
  • 10[8]Nakashima M,Uematsu T,Kosuge K, et al. Single and multiple-dose pharmacolinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans. Antimicrobial Agents Chemotherapy,1995;39:2635~2640.

共引文献90

同被引文献46

  • 1田治明.新喹诺酮抑制DNA旋转酶活性的作用机制[J].国外医药(抗生素分册),1995,16(2):115-118. 被引量:6
  • 2傅绍军,朱利民,洪枫.抗HIV和HBV新药L-D4FC[J].中国新药杂志,2005,14(9):1201-1205. 被引量:3
  • 3夏路风,刘蕾,傅得兴.新型广谱三唑类抗真菌药泊沙康唑[J].中国新药杂志,2007,16(15):1226-1231. 被引量:8
  • 4William BE. Capecitabine use in geriatric oncology: an analysis of current safety, efficacy, and quality of life data [J]. Critical Reviews in Oncology/Hematology, 2006, 58 (1): 68.
  • 5Monica MS, Miguel AC, Raquel de Paz, et al. Treatment-related acute myeloid leukemia with 11q23 translocation following treatment with fludarabine, cyclophosphamide and rituximab[J]. Leukemia Research, 2008, 32 (1): 199.
  • 6Myrna CA, Lucely C, de la Garza J, et al. Clinical implications of gemcitabine in the treatment of cervical cancer[J]. Critical Reviews in Oncology/Hematology, 2007, 61(3): 230.
  • 7Laurence B, Alain P, Nathalie D, et al. Emtricitabine: inhibitor and substrate of multidrug resistance associated protein [J]. European Journal of Pharmaceutical Sciences,2008, 35(4):247.
  • 8Constantine GB, Richard LM, David YM, et al. Synthesis and anti-HIV activity of GS-9148 (2'-Fd4AP), a novel nucleoside phosphonate HIV reverse transcriptase inhibitor[J]. Bioorganic & Medicinal Chemistry Letters, 2008, 18(3): 1 120.
  • 9Liu P, Sharon A, Chu CK. Fluorinated nucleosides : synthesis and biological implication[J]. Journal of Fluorine Chemistry,2008, 129(9) : 743.
  • 10Shi JX, Du JF, Ma TW, et al. Synthesis and anti-viral activity of a series of D-and L-2'-deoxy-2'-fluororibonucleosides in the subgenomic HCV replicon system[J]. Bioorganic & Medicinal Chemistry, 2005, 13(5) : 1 641.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部